1,036
Views
15
CrossRef citations to date
0
Altmetric
Research Paper

Prevalence and genotype distribution of human papillomavirus among women with cervical lesions in Shenzhen city, China

, ORCID Icon, , &
Pages 965-971 | Received 14 May 2020, Accepted 02 Aug 2020, Published online: 22 Sep 2020

Figures & data

Table 1. Distribution of human papillomavirus genotypes according to the final diagnoses among the 5,255 patients

Table 2. Single and multiple infection status in patients with HPV infection

Figure 1. Distribution of the five most prevalent HPV genotypes according to diagnosis. HPV, human papillomavirus; LSIL, low-grade squamous intraepithelial lesion; HSIL, high-grade squamous intraepithelial lesion; ICC, invasive cervical carcinoma

Figure 1. Distribution of the five most prevalent HPV genotypes according to diagnosis. HPV, human papillomavirus; LSIL, low-grade squamous intraepithelial lesion; HSIL, high-grade squamous intraepithelial lesion; ICC, invasive cervical carcinoma

Figure 2. Rate of total and high-risk HPV infection across all age groups among 5,255 gynecology outpatients in Shenzhen city, China. HPV, human papillomavirus

Figure 2. Rate of total and high-risk HPV infection across all age groups among 5,255 gynecology outpatients in Shenzhen city, China. HPV, human papillomavirus
Supplemental material

Supplemental Material

Download MS Word (58.9 KB)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.